Antisense Inhibition of Apolipoprotein C-III in Patients with HypertriglyceridemiaDaniel Gaudet, John J.P. Kastelein, Nicholas J. Viney et al.|New England Journal of Medicine|2015Cited by 526
Targeting APOC3 in the Familial Chylomicronemia SyndromeDaniel Gaudet, Joseph L. Witztum, Diane Brisson et al.|New England Journal of Medicine|2014Cited by 492
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trialDaniel Gaudet, S van Deventer, Julie Méthot et al.|Gene Therapy|2012Cited by 399
ANGPTL3 Inhibition in Homozygous Familial HypercholesterolemiaDaniel Gaudet, G. Kees Hovingh, Daniel A. Gipe et al.|New England Journal of Medicine|2017Cited by 329